INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Invivo Therapeutics Holdings Corp. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 3.11M shares, a 123% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.11M +1.71M +123% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 3.11M +1.71M +123% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 3.11M +1.73M +127% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 2.43M +1.06M +77.3% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 1.39M -32.9M -95.9% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 1.39M -32.9M -95.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 1.37M -32.9M -96% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 1.37M -22.3M -94.2% Dec 31, 2021 10-K 2023-03-01
Q3 2021 34.3M +29.4M +602% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 34.3M +29.4M +602% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 34.3M +31.7M +1232% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 23.6M +23.1M +4191% Dec 31, 2020 10-K 2022-03-07
Q3 2020 4.88M -4.64M -48.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 4.88M -4.43M -47.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 2.57M -6.74M -72.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 551K +240K +77.5% Dec 31, 2019 10-K 2021-03-01
Q3 2019 9.52M +1.01M +11.9% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 9.31M +5.23M +128% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 9.31M +7.75M +496% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 310K -1.06M -77.4% Dec 31, 2018 10-K 2020-02-20
Q3 2018 8.51M -25.7M -75.2% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 4.08M -28.1M -87.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 1.56M -30.6M -95.1% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 1.37M -30.7M -95.7% Dec 31, 2017 10-K 2019-04-01
Q3 2017 34.2M +2.2M +6.87% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 32.2M +258K +0.81% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 32.1M +218K +0.68% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 32M +4.49M +16.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 32M +4.99M +18.5% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 31.9M +5.06M +18.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 31.9M +5.89M +22.7% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 27.6M +4.1M +17.5% Dec 31, 2015 10-K 2017-03-10
Q3 2015 27M -66.5M -71.1% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 26.9M -66.6M -71.3% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 26M -53M -67.1% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 23.5M -55.3M -70.2% Dec 31, 2014 10-K 2016-03-04
Q3 2014 93.5M +14.8M +18.8% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 93.4M +15.1M +19.2% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 79M +12.8M +19.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 78.8M +12.9M +19.6% Dec 31, 2013 10-K 2015-03-11
Q3 2013 78.7M +13.1M +20% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 78.4M +13.7M +21.1% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 66.2M +2.26M +3.54% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 65.9M +12.1M +22.5% Dec 31, 2012 10-K 2014-03-17
Q3 2012 65.6M +13.6M +26.2% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 64.7M +13M +25% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 63.9M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 53.8M +2.11M +4.09% Dec 31, 2011 10-K 2013-03-12
Q3 2011 52M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 51.7M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 51.6M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.